Vice President, Product Evaluation & Early Stage Development
Dr. Romano is responsible for evaluation and preclinical development of HUYABIO’s in-licensed drug candidates. Dr. Romano has “hands-on” as well as management experience from pharmaceutical and biotech companies. She has skills in drug discovery, preclinical development, corporate partnering, and alliance management in a broad range of therapeutic areas including oncology, diabetes, inflammation, and CNS disorders. With more than 20 years industry experience, she has provided scientific business development consulting services to several biotech companies. She was previously Director of Business Development at Novasite Pharmaceuticals, and served in corporate development and drug discovery positions at Ontogen Corporation. Prior to that, she was a member of the biotechnology product development group at Johnson & Johnson. Dr. Romano received a PhD in Biology/Neurobiology from the University of California, San Diego, and an AB in Biology from Princeton University.